Clinical Trial Update: Vinblastine for Leukoreduction in Newly Diagnosed AML and Hyperleukocytosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating vinblastine for leukoreduction in newly diagnosed acute myeloid leukemia with hyperleukocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Hyperleukocytosis

Drugs mentioned

• Vinblastine (vinblastine)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: AML, Hyperleukocytosis | Phase 2 | Status: UNKNOWN